5 hasil untuk "Shane M Devlin"

Complementary and alternative medications in the management of inflammatory bowel disease

Sherman Picardo; Mansour Altuwaijri; Shane M. Devlin dkk.

Therapeutic Advances in Gastroenterology, Vol. 13 · 2020 · Inggris · DOAJ Scopus

The use of complementary and alternative medications (CAM), products, and therapies not considered to be part of conventional medicine is common among patients with inflammatory bowel disease (IBD). Patients often turn to these therapies as they are considered natural and safe, with significant…

A Survey of Perceptions and Practices of Complementary Alternative Medicine among Canadian Gastroenterologists

Zane Gallinger; Brian Bressler; Shane M Devlin dkk.

Canadian Journal of Gastroenterology and Hepatology, Vol. 28 No. 1 · 2014 · Inggris · DOAJ Scopus

BACKGROUND: Despite a high prevalence of complementary alternative medicine (CAM) use among inflammatory bowel disease (IBD) patients, there is a dearth of information about the attitudes and perceptions of CAM among the gastroenterologists who treat these patients.

Mycophenolate Mofetil for the Treatment of Autoimmune Hepatitis in Patients Refractory to Standard Therapy

Shane M Devlin; Mark G Swain; Stefan J Urbanski dkk.

Canadian Journal of Gastroenterology, Vol. 18 No. 5 · 2004 · Inggris · DOAJ

There are limited therapeutic options available for patients with autoimmune hepatitis in whom conventional treatment fails. A case series of five patients unresponsive to or unable to take azathioprine, 6-mercaptopurine or corticosteroids who were treated with mycophenolate mofetil (MMF) is…

Overview of Subsequent Entry Biologics for the Management of Inflammatory Bowel Disease and Canadian Association of Gastroenterology Position Statement on Subsequent Entry Biologics

Shane M Devlin; Brian Bressler; Charles N Bernstein dkk.

Canadian Journal of Gastroenterology, Vol. 27 No. 10 · 2013 · Inggris · DOAJ

Defining Quality Indicators for Best-Practice Management of Inflammatory Bowel Disease in Canada

Geoffrey C Nguyen; Shane M Devlin; Waqqas Afif dkk.

Canadian Journal of Gastroenterology and Hepatology, Vol. 28 No. 5 · 2014 · Inggris · DOAJ Scopus

BACKGROUND: There is a paucity of published data regarding the quality of care of inflammatory bowel disease (IBD) in Canada. Clinical quality indicators are quantitative end points used to guide, monitor and improve the quality of patient care. In Canada, where universal health care can vary…